Metformin Use Is Associated With Reduced Rates of Primary Nerve Decompression Surgery and Revision in Type 2 Diabetes: A Retrospective Cohort Study.
- 1Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO.
Abstract
Purpose
Type 2 diabetes mellitus is a risk factor for compressive neuropathy. The purpose of this study was to determine whether metformin use is associated with reduced rates of compressive neuropathy, primary nerve decompression surgery, and revision after carpal tunnel release and cubital tunnel release, while controlling for concurrent diabetes medications.Methods
We performed a retrospective cohort study using the TriNetX federated research network. Adults with type 2 diabetes mellitus were stratified by metformin exposure, defined as at least 10 prescriptions over 5 years. The primary outcomes were incident compressive neuropathy and nerve decompression surgery. In a unilateral revision cohort, the outcome was ipsilateral revision between 30 days and 5 years after the index procedure. One-to-one propensity score matching balanced cohorts on demographics, comorbidities, and concurrent diabetes medications. Four prespecified medication-stratified sensitivity analyses addressed insulin, sodium-glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists. Carpal tunnel release and cubital tunnel release revision results were pooled via fixed-effect meta-analysis.Results
After matching, the primary analysis included 260,823 pairs. Metformin users had lower rates of nerve decompression surgery (0.60% vs 0.72%; odds ratio, OR, 0.831 [0.776-0.889]) and compressive neuropathy diagnosis (2.78% vs 3.05%; OR, 0.909 [0.879-0.941]). The surgery-level association was stronger without concurrent insulin (OR, 0.727 [0.662-0.799]) and attenuated to nonsignificance with concurrent insulin (OR, 0.948 [0.836-1.076]), though the diagnosis-level association persisted. Among patients with unilateral carpal or cubital tunnel syndrome, ipsilateral revision was less frequent in metformin users (pooled OR, 0.711 [0.533-0.950]). Metformin users also had lower vitamin B12 levels (mean, 646.4 vs 707.4 pg/mL), consistent with sustained metformin exposure.Conclusions
Metformin use was associated with reduced incidence of nerve decompression surgery and ipsilateral revision after carpal tunnel release and cubital tunnel release in patients with type 2 diabetes mellitus, with directionally consistent effects across sensitivity analyses. These findings suggest that maintaining metformin therapy may carry benefit beyond glycemic control. Prospective studies are needed to validate these findings.Type of study/level of evidence
Prognostic II.
Related
- Prevalence and associated factors of vitamin B12 deficiency among Vietnamese patients with type 2 diabetes receiving metformin therapy: a cross-sectional study
- Comparative effectiveness of initiating insulin versus metformin therapy for gestational diabetes mellitus in China: a retrospective cohort study
- MetCool ACS: study protocol for a multicentre quasi-randomised trial of metformin in patients without diabetes after acute coronary syndrome in Poland.
- Effects of Metformin on Clinical Outcomes After Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors
BibTeX
@article{abbas2026metformin,
title = {{Metformin Use Is Associated With Reduced Rates of Primary Nerve Decompression Surgery and Revision in Type 2 Diabetes: A Retrospective Cohort Study.}},
author = {Yamen Abbas and Amir Kucharski and Adam Boukind and David Wright and Christopher J Dy and David M Brogan},
journal = {Journal of hand surgery global online},
year = {2026},
month = oct,
doi = {10.1016/j.jhsg.2026.101148},
url = {https://europepmc.org/article/MED/42927270},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Metformin Use Is Associated With Reduced Rates of Primary Nerve Decompression Surgery and Revision in Type 2 Diabetes: A Retrospective Cohort Study.
AU - Yamen Abbas
AU - Amir Kucharski
AU - Adam Boukind
AU - David Wright
AU - Christopher J Dy
AU - David M Brogan
PY - 2026
DA - 2026/10/19
JO - Journal of hand surgery global online
DO - 10.1016/j.jhsg.2026.101148
UR - https://europepmc.org/article/MED/42927270
AB - Purpose Type 2 diabetes mellitus is a risk factor for compressive neuropathy. The purpose of this study was to determine whether metformin use is associated with reduced rates of compressive neuropathy, primary nerve decompression surgery, and revision after carpal tunnel release and cubital tunnel release, while controlling for concurrent diabetes medications.Methods We performed a retrospective cohort study using the TriNetX federated research network. Adults with type 2 diabetes mellitus were stratified by metformin exposure, defined as at least 10 prescriptions over 5 years. The primary outcomes were incident compressive neuropathy and nerve decompression surgery. In a unilateral revision cohort, the outcome was ipsilateral revision between 30 days and 5 years after the index procedure. One-to-one propensity score matching balanced cohorts on demographics, comorbidities, and concurrent diabetes medications. Four prespecified medication-stratified sensitivity analyses addressed insulin, sodium-glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists. Carpal tunnel release and cubital tunnel release revision results were pooled via fixed-effect meta-analysis.Results After matching, the primary analysis included 260,823 pairs. Metformin users had lower rates of nerve decompression surgery (0.60% vs 0.72%; odds ratio, OR, 0.831 [0.776-0.889]) and compressive neuropathy diagnosis (2.78% vs 3.05%; OR, 0.909 [0.879-0.941]). The surgery-level association was stronger without concurrent insulin (OR, 0.727 [0.662-0.799]) and attenuated to nonsignificance with concurrent insulin (OR, 0.948 [0.836-1.076]), though the diagnosis-level association persisted. Among patients with unilateral carpal or cubital tunnel syndrome, ipsilateral revision was less frequent in metformin users (pooled OR, 0.711 [0.533-0.950]). Metformin users also had lower vitamin B12 levels (mean, 646.4 vs 707.4 pg/mL), consistent with sustained metformin exposure.Conclusions Metformin use was associated with reduced incidence of nerve decompression surgery and ipsilateral revision after carpal tunnel release and cubital tunnel release in patients with type 2 diabetes mellitus, with directionally consistent effects across sensitivity analyses. These findings suggest that maintaining metformin therapy may carry benefit beyond glycemic control. Prospective studies are needed to validate these findings.Type of study/level of evidence Prognostic II.
SN - 2589-5141
ER -